Replies to post #28023 on Seelos Therapeutics Inc (SEEL)

[mecosmo2]

(4/12): Apricus Biosciences (NASDAQ:APRI): Pre-IND meeting with FDA on Vitaros for erectile dysfunction.

[casinokid11211]

Wrong Aprilov, you Pascoe lovers will vote to increase the outstanding shares to 60 mill, FDA will require new studies, that will put an end to Vitaros, Pascoe will then want to develop Rayva which has no revenue potential at all. He will ride this out another three years unless you guys vote no to increase the outstanding shares, then he has no other option than to sell.